|
Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System
RECRUITINGSponsored by Fondazione Don Carlo Gnocchi Onlus
Actively Recruiting
SponsorFondazione Don Carlo Gnocchi Onlus
Started2022-05-13
Est. completion2027-04-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05493514
Summary
The aim of this work is to elaborate a statistical model to predict the effectiveness of robotic treatment in subjects with neurological diseases. The model will be used to understand which subjects are most responsive to this type of treatment
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Diagnosis of Multiple Sclerosis, Parkinson Disease, Stroke or acquired brain injury * Minimum number of sessions: 10 sessions with the GEO system * Minimum frequency of sessions: 2 per week * Age ≥ 18 years * Ability to walk for at least 10 meters, also with aid * Indication of robotic treatment in the therapeutic plan * Body size suitable for the robotic device * ability to maintain verticality for 7 minutes; * ability to maintain the sitting position without support for 30 seconds; Exclusion Criteria: * severe limitations of articular range of motion; * medical problems compromising walking (e.g. fractures, pain, severe osteoporosis or severe spasticity); * Presence of skin lesions in the areas of contact with the device; * Presence of seizures that may be triggered by the use of the G-EO system.
Conditions4
Acquired Brain InjuryMultiple SclerosisParkinson DiseaseStroke
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorFondazione Don Carlo Gnocchi Onlus
Started2022-05-13
Est. completion2027-04-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05493514